HONG KONG, Nov. 16, 2017 /PRNewswire/ -- Golden Meditech
Holdings Limited (SEHK stock code: 00801, TWSE stock code:
910801) ("Golden Meditech" or the "Company", together with its
subsidiaries, the "Group"), a leading integrated healthcare
enterprise in China, today
announces that it has formed a strategic collaboration with GE
Healthcare. Pursuant to the collaboration, GE Healthcare will
provide an integrated and automated digital system and solutions to
the Group's umbilical cord blood cryopreservation processes, aiming
to provide efficient storage services to customers at large.
Medical research in the past three decades have shown that
umbilical cord blood contains rich hematopoietic stem cells. These
stem cells could facilitate the reconstruction of hematopoietic and
immune systems, and could also be applied to hematopoietic stem
cell transplantation as well as the treatment of blood system,
immune system and inherited metabolic diseases. Therefore,
umbilical cord blood has become an important source of
hematopoietic stem cells and is widely used clinically. Cord blood
bank operation usually include cord blood collection and
processing, laboratory testing, stem cell cryopreservation and
storage. All these processes demanded high standard
protocols. Through its partnership with GE Healthcare, the Group
will utilise a fully automated cell processing system and
associated disposable kit to meet the stringent requirements for
extensive cord blood processing in an efficient and safe
manner.
About Golden Meditech Holdings Limited (SEHK stock code:
00801, TWSE stock code: 910801)
Golden Meditech (www.goldenmeditech.com) is a leading
integrated-healthcare enterprise in China. It is a first-mover in China, having established its dominant
positions in several markets including the medical devices market,
the cord blood storage market and the hospital management market in
the healthcare industry, thanks to its strengths in innovation and
market expertise and the ability to capture emerging market
opportunities. Going forward, Golden Meditech will continue to
pursue a leading position in China's healthcare industry both through
organic growth and strategic expansion.
About GE Healthcare
GE Healthcare, a subsidiary of GE (NYSE stock code: GE),
provides innovative medical technologies and services that meet the
needs of people across the world, offering them access to more
affordable healthcare services. Focusing on multi-critical issues
in the world, GE is committed to meeting the major industrial
challenges using its talents and cutting-edge technologies. GE
Healthcare assists healthcare professionals in delivering quality
healthcare services to patients in a variety of fields, including
medical imaging, software and information technology, patient
monitoring and diagnosis, drug research and development,
biopharmaceuticals and operational excellence solutions.
View original
content:http://www.prnewswire.com/news-releases/golden-meditech-and-ge-healthcare-team-up-to-develop-safe-and-efficient-cord-blood-storage-services-300557517.html
SOURCE Golden Meditech Holdings Limited